Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides · page 12 of 33
The slide illustrates the transition from a 177Lu-based molecule (IPN-1087) to a 225Ac-based molecule (FPI-2059) to improve efficacy.
Pitch deck · product_demo · present_solution · dense density
Slide locked Sign in to view
Slide schematic 5/5
callout 1/1 chart 1/1 image 1/1 title 2/2
Components 5
primary line illustration action-title headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.